|
Status |
Public on Dec 31, 2021 |
Title |
SF8386 |
Sample type |
genomic |
|
|
Source name |
FFPE GBM Recurrent tumor sample, Trial arm: Control
|
Organism |
Homo sapiens |
Characteristics |
tissue: glioblastoma tumor subject: Subject_C7 primary_recurrence: Recurrent slide: 402993420054/2 array: R05C01 ChIP: 829266 age (years): 55 Sex: M vital status: Dead overall survival (days): 939 treatment time (days): NA trial arm: Control estimated sample purity: 0.956067849 fresh frozen (ff) or ffpe: FFPE
|
Extracted molecule |
genomic DNA |
Extraction protocol |
genomic DNA was extracted and purified from samples using Qiagen DNeasy Kit according to standard instructions
|
Label |
Cy5 and Cy3
|
Label protocol |
Standard Illumina Protocol
|
|
|
Hybridization protocol |
bisulphite converted DNA was amplified, fragmented and hybridised to Illumina Infinium HumanMethylationEPIC Beadchip using standard Illumina protocol
|
Scan protocol |
Arrays were imaged using BeadArray Reader using standard recommended Illumina scanner setting
|
Description |
201496710027_R05C01
|
Data processing |
BeadStudio software
|
|
|
Submission date |
Mar 09, 2018 |
Last update date |
Dec 31, 2021 |
Contact name |
Lucas A. Salas |
E-mail(s) |
[email protected]
|
Organization name |
Geisel School of Medicine at Dartmouth
|
Department |
Epidemiology
|
Lab |
Salas Lab
|
Street address |
1 Medical Center Dr, DHMC
|
City |
Lebanon |
State/province |
NH |
ZIP/Postal code |
03756 |
Country |
USA |
|
|
Platform ID |
GPL21145 |
Series (1) |
GSE111627 |
DNA methylome evolution and reprogramming in recurrent glioblastoma |
|